Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 14, 2026
DataAggregated Company Financials
Companies9
- 7D-1.5%
- 3M7.7%
- 1Y21.7%
- YTD4.3%
Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Merck KGaA declining 2.6%. In the past year, the industry has gained 22%. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 14 Jun 2026 | €96.7b | €67.4b | €482.5m | 22.9x | 200.4x | 1.4x |
| Tue, 12 May 2026 | €88.6b | €67.9b | -€888,697,442.38 | 18.2x | -99.7x | 1.3x |
| Thu, 09 Apr 2026 | €91.9b | €67.9b | -€900,272,004.10 | 19.1x | -102x | 1.4x |
| Sat, 07 Mar 2026 | €86.8b | €67.9b | -€902,794,919.14 | 18.1x | -96.1x | 1.3x |
| Mon, 02 Feb 2026 | €101.1b | €68.3b | €2.9b | 17.3x | 35.3x | 1.5x |
| Wed, 31 Dec 2025 | €92.6b | €68.3b | €2.9b | 18.1x | 32.3x | 1.4x |
| Fri, 28 Nov 2025 | €83.6b | €68.5b | €2.9b | 17.4x | 29x | 1.2x |
| Sun, 26 Oct 2025 | €80.3b | €68.8b | -€439,053,836.05 | 19.2x | -183x | 1.2x |
| Tue, 23 Sep 2025 | €77.4b | €68.8b | -€438,193,069.03 | 17.9x | -176.7x | 1.1x |
| Thu, 21 Aug 2025 | €79.1b | €68.9b | -€409,598,873.65 | 17.6x | -193.2x | 1.1x |
| Sat, 19 Jul 2025 | €77.7b | €69.4b | -€283,071,598.00 | 17.4x | -274.5x | 1.1x |
| Mon, 16 Jun 2025 | €79.4b | €69.4b | -€206,268,848.00 | 18x | -385.1x | 1.1x |
| Wed, 14 May 2025 | €81.9b | €69.3b | €463.8m | 19.3x | 176.7x | 1.2x |
| Fri, 11 Apr 2025 | €71.0b | €69.3b | €467.0m | 17.4x | 151.9x | 1x |
| Sun, 09 Mar 2025 | €84.5b | €69.2b | €436.0m | 21.2x | 193.7x | 1.2x |
| Tue, 04 Feb 2025 | €87.7b | €69.2b | €2.0b | 23.2x | 43.2x | 1.3x |
| Thu, 02 Jan 2025 | €82.5b | €69.2b | €2.0b | 22.6x | 41.1x | 1.2x |
| Sat, 30 Nov 2024 | €83.1b | €69.2b | €2.0b | 21.4x | 41.1x | 1.2x |
| Mon, 28 Oct 2024 | €95.5b | €69.4b | €1.6b | 20.3x | 61.2x | 1.4x |
| Wed, 25 Sep 2024 | €98.6b | €69.3b | €1.5b | 23.8x | 66.9x | 1.4x |
| Fri, 23 Aug 2024 | €103.6b | €69.3b | €1.5b | 31.1x | 71.1x | 1.5x |
| Sun, 21 Jul 2024 | €93.3b | €69.2b | -€303,627,757.00 | 28.9x | -307.4x | 1.3x |
| Tue, 18 Jun 2024 | €102.7b | €69.2b | -€328,028,608.00 | 23.2x | -313x | 1.5x |
| Thu, 16 May 2024 | €103.5b | €69.4b | -€249,446,124.76 | 21.1x | -415.1x | 1.5x |
| Sat, 13 Apr 2024 | €95.7b | €70.0b | -€34,208,180.00 | 20.8x | -2796.8x | 1.4x |
| Mon, 11 Mar 2024 | €96.7b | €70.0b | €6.5m | 20x | 14883.2x | 1.4x |
| Wed, 07 Feb 2024 | €96.6b | €70.6b | -€650,504,143.00 | 20x | -148.6x | 1.4x |
| Fri, 05 Jan 2024 | €99.6b | €70.6b | -€650,504,143.00 | 19.5x | -153.1x | 1.4x |
| Sun, 03 Dec 2023 | €102.3b | €70.6b | -€650,606,256.00 | 19x | -157.2x | 1.4x |
| Tue, 31 Oct 2023 | €102.3b | €72.1b | €4.7b | 17x | 21.9x | 1.4x |
| Thu, 28 Sep 2023 | €115.2b | €72.1b | €4.7b | 21.9x | 24.6x | 1.6x |
| Sat, 26 Aug 2023 | €122.1b | €72.1b | €4.7b | 22.6x | 26.2x | 1.7x |
| Mon, 24 Jul 2023 | €121.5b | €74.1b | €6.5b | 18.8x | 18.8x | 1.6x |
| Wed, 21 Jun 2023 | €120.6b | €74.1b | €6.4b | 20.8x | 18.8x | 1.6x |
Price to Earnings Ratio
18.8x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 200x which is higher than its 3-year average PE of 129x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.72% | |
| Healthcare | -0.88% | |
| Pharma | -1.51% | |
| Pharma | -1.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DMP Dermapharm Holding | €48.65 | 2.3% +€54.5m | 37.8% | PE16.7x | |
| BAYN Bayer | €36.19 | 0.08% +€29.5m | 31.7% | PS0.8x | |
| 93M1 MPH Health Care | €27.10 | 3.8% +€4.3m | 38.6% | PS2.3x |